BJ
IONS icon

BlackRock Japan’s Ionis Pharmaceuticals IONS Stock Holding History

BlackRock Japan’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-145,300
Closed -$3.38M – 1363
2016
Q2 		$3.38M Hold
145,300
– – 0.01% 661
2016
Q1 		$5.88M Sell
145,300
-222
-0.2% -$9.02K 0.02% 606
2015
Q4 		$9.01M Sell
145,522
-272
-0.2% -$14.7K 0.03% 531
2015
Q3 		$5.89M Buy
145,794
+1,826
+1% +$94.5K 0.02% 595
2015
Q2 		$8.29M Sell
143,968
-625
-0.4% -$39.7K 0.03% 572
2015
Q1 		$9.21M Buy
144,593
+142,250
+6,071% +$9.65M 0.04% 521
2014
Q4 		$145K Sell
2,343
-3,091
-57% -$153K ﹤0.01% 920
2014
Q3 		$211K Sell
5,434
-2,614
-32% -$92.6K ﹤0.01% 839
2014
Q2 		$277K Buy
8,048
+2,858
+55% +$90K ﹤0.01% 796
2014
Q1 		$224K Buy
5,190
+2,443
+89% +$118K ﹤0.01% 917
2013
Q4 		$109K Sell
2,747
-4,551
-62% -$162K ﹤0.01% 1010
2013
Q3 		$274K Sell
7,298
-14,700
-67% -$439K ﹤0.01% 844
2013
Q2 		$591K Buy
+21,998
New +$468K ﹤0.01% 705

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Japan's IONS Position: Q3 2016 in Review

BlackRock Japan sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 145,300 shares — an estimated $3.38M sold.

BlackRock Japan first reported a position in IONS in Q2 2013 and held it in 13 quarters. The position peaked at $9.21M in Q1 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

  • BlackRock Japan reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 145,300 Ionis Pharmaceuticals shares in Q3 2016, an estimated $3.38M.
  • BlackRock Japan first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • BlackRock Japan's Ionis Pharmaceuticals position peaked at $9.21M in Q1 2015.
  • 281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.